Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Sexual aid device
Built-in electric air pump for use in inflatable products
Multifunctional electromagnetic transducer
Multidimensional data input interface
Magnetic resonance imaging
Methods and apparatus for simulation speedup
Apparatus and method for boosting output of a generator set
  Randomly Featured Patents
Glass edging
Manifold assembly
Asymmetrical p-channel transistor having a boron migration barrier and LDD implant only in the drain region
Methods for creating a group practice
Expandable structures for deployment in interior body regions
Insulating plate and process for the preparation thereof
Method and device for the storage of selected points of a nominal contour line in a projection profile grinder
Stand alone divider for shelving
Method and apparatus providing redundancy for fabricating highly reliable memory modules
Single facer and corrugating roll for the same